Pay in 4 interest-free payments of $6.83 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications originally developed for type 2 diabetes management, with some now specifically licensed for weight management in the UK
Metabolic Syndrome, Diabetes, and Hyperuricemia
Long-term metabolic stability improves
At the same time, pharma companies continue developing lower-volume therapiesmaking it essential for CDMOs to support both large-scale and niche projects
Pang J, Feng JN, Ling W, Jin T (2022) The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs-therapeutic potential exploration in lung injury
US$ 24.42
US$ 24.01
US$ 23.62
US$ 21.35
US$ 23.86
US$ 25.86
US$ 29.40
US$ 24.06
